Post-locoregional therapy imaging of the liver

Nasir Siddiqui*, Hüseyin Gürkar Töre, Vahid Yaghmai

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In patients with non-resectable malignant liver tumors, therapy may include systemic chemotherapy or locoregional therapy. Locoregional therapy may decrease, stabilize, or increase the size of these tumors, depending on the specific approach taken. As a result, the assessment of response to locoregional therapy requires familiarity with the appearance of tumors after each type of therapy. New guidelines are being developed in order to better evaluate tumor response to specific therapies. This chapter will discuss the imaging findings of hepatic tumors undergoing locoregional therapy and the methods of assessing response to therapy.

Original languageEnglish (US)
Title of host publicationCross-Sectional Imaging of the Abdomen and Pelvis
Subtitle of host publicationA Practical Algorithmic Approach
PublisherSpringer New York
Pages97-109
Number of pages13
ISBN (Electronic)9781493918843
ISBN (Print)9781493918836
DOIs
StatePublished - Jan 1 2015

Keywords

  • Hepatocellular carcinoma
  • Locoregional therapy
  • Response to therapy
  • mRECIST

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Post-locoregional therapy imaging of the liver'. Together they form a unique fingerprint.

  • Cite this

    Siddiqui, N., Töre, H. G., & Yaghmai, V. (2015). Post-locoregional therapy imaging of the liver. In Cross-Sectional Imaging of the Abdomen and Pelvis: A Practical Algorithmic Approach (pp. 97-109). Springer New York. https://doi.org/10.1007/978-1-4939-1884-3_4